{"key":"op_790_TR","page":{"url":"https://fr.bookimed.com/clinics/country=turkey/procedure=target-therapy-for-lung-cancer/","procedure":{"id":790,"slug":"target-therapy-for-lung-cancer","name":"Thérapie ciblée pour le cancer du poumon","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":46,"iso":"TR","name":"Turquie"},"currency":"USD","data_date":"2025-08-10"},"pages":{"clinics_url":"https://fr.bookimed.com/clinics/country=turkey/procedure=target-therapy-for-lung-cancer/","cost_url":"https://fr.bookimed.com/clinics/country=turkey/procedure=target-therapy-for-lung-cancer/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":5000,"to":5800,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":90000,"to":150000},"uk":{"from":14000,"to":25000},"by_technique":[{"technique":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","technique_id":"oral-egfr-tyrosine","price_from":5000,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","technique_id":"other-oral-targeted","price_from":5000,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","technique_id":"antibody-based-targeted","price_from":5500,"currency":"USD","source":"estimate","date":"2026-11-17"}],"by_city":[{"city":"Istanbul","from":5000},{"city":"Bursa","from":5800},{"city":"Antalya","from":2200},{"city":"Izmir","from":2500}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":3500,"to":7000},{"country_iso":"FR","from":6500,"to":13000},{"country_iso":"GB","from":14000,"to":25000},{"country_iso":"US","from":90000,"to":150000},{"country_iso":"IL","from":9000,"to":16000},{"country_iso":"MX","from":6500,"to":12000},{"country_iso":"DE","from":3000,"to":27000},{"country_iso":"CA","from":9000,"to":20000},{"country_iso":"AE","from":9000,"to":14000},{"country_iso":"TH","from":9000,"to":13500},{"country_iso":"PL","from":4500,"to":8500},{"country_iso":"KR","from":2500,"to":15000},{"country_iso":"CZ","from":4500,"to":9000},{"country_iso":"AT","from":9000,"to":18000},{"country_iso":"ES","from":4500,"to":13000},{"country_iso":"IT","from":8200,"to":15900},{"country_iso":"CN","from":1600,"to":13000},{"country_iso":"AU","from":3800,"to":7500},{"country_iso":"IN","from":1000,"to":5500},{"country_iso":"MY","from":1800,"to":5400},{"country_iso":"VN","from":5000,"to":9500},{"country_iso":"BR","from":4500,"to":7000}],"base_country":"US","base_is_fallback":false},"savings":{"pct":94,"variant":">=15%"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":8,"items":[{"id":96,"name":"Memorial Şişli Hospital","city":"Istanbul","rating":4.6,"reviews_count":437,"accreditations":["International Organization for Standardization","Joint Commission International"],"rank":1,"has_procedure":true,"why_ranked":"Extended NGS panel checks RET, ROS1, MET, NTRK, BRAF and HER2 mutations to broaden targeted therapy options. PD-L1 testing guides immunotherapy. JCI-accredited care follows NCCN and ESMO protocols.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":410,"name":"Memorial Bahçelievler Hospital","city":"Istanbul","rating":4.6,"reviews_count":165,"accreditations":["International Organization for Standardization","Joint Commission International"],"rank":2,"has_procedure":true,"why_ranked":"Targeted therapy for EGFR-mutated NSCLC, may include amivantamab – a drug not widely available. PET-CT included. Plans set by multidisciplinary oncology councils.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":87,"name":"Anadolu Medical Center","city":"Istanbul","rating":4.6,"reviews_count":545,"accreditations":["Planetree's Gold Certificate","International Accreditation System for Interventional Oncology Services (IASIOS)","Patient choice in Oncology & Hematology Oncology","Patient Choice for Basic Check-up","Johns Hopkins Medicine","Organisation of European Cancer Institutes Certificate","European Society for Medical Oncology","Joint Commission International","International Organization for Standardization","World's Best Hospitals 2026 by Newsweek"],"rank":3,"has_procedure":true,"why_ranked":"Utilizes CyberKnife and Truebeam for precise radiation therapy, offering high accuracy down to 0.5 mm. Specialized oncologists treat lung cancer with advanced robotic techniques.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":426,"name":"Hisar Hospital Intercontinental","city":"Istanbul","rating":4.5,"reviews_count":267,"accreditations":["Joint Commission International","Turkish Medical Association (Türk Tabıplerı Bırliği)","Turkish Medical Association","Patient choice in Oncology & Hematology Oncology","Best patient assistance","Best clinic for radiotherapy"],"rank":4,"has_procedure":true,"why_ranked":"Offers targeted immunotherapy with pembrolizumab, administered every 3 weeks. JCI-accredited facility with comprehensive cancer care team. Includes pre-treatment lab tests and PET-CT if needed.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":1173,"name":"Emsey Hospital","city":"Istanbul","rating":4.1,"reviews_count":42,"accreditations":["The Baby-friendly Hospital Initiative (BFHI) by WHO and UNICEF","Turkish Medical Association","TEMOS International Healthcare Accreditation","Certification according to DIN EN ISO 9001 by TÜV NORD CERT","International Health Tourism Authorization Certificate","International Organization for Standardization"],"rank":5,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":1602,"name":"Acibadem Altunizade Clinic","city":"Istanbul","rating":4.4,"reviews_count":7,"accreditations":["International Organization for Standardization","Joint Commission International","LEED Platinum Sertificate for ECO Buildings"],"rank":6,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":4464,"name":"Private Medicabil Hospital","city":"Bursa","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":["International Organization for Standardization","International Health Tourism Authorization Certificate","Joint Commission International"],"rank":7,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":4960,"name":"BP Klinik","city":"Turkey","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":["Turkish Medical Association","International Health Tourism Authorization Certificate","Turkish Medical Association (Türk Tabıplerı Bırliği)"],"rank":8,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":12,"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":107,"slug":"istanbul","name":"Istanbul","clinics_count":1,"price_from":5000,"profile":{"city_type":"Largest city in Turkey, megacity","access":["Sabiha Gökçen Airport (SAW), 32 km southeast of city center"],"sources":["https://en.wikipedia.org/wiki/Istanbul","https://en.wikipedia.org/wiki/Sabiha_G%C3%B6k%C3%A7en_International_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":348,"slug":"bursa","name":"Bursa","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":5800,"profile":{"city_type":"City in northwestern Turkey","access":["Yenişehir Airport (YEI), 49 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Bursa"],"checked_at":"2026-11-03","status":"ok"}},{"id":382,"slug":"antalya","name":"Antalya","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":2200,"profile":{"city_type":"Major Mediterranean coastal city in Turkey","access":["Antalya Airport (AYT), 13 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Antalya","https://en.wikipedia.org/wiki/Antalya_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":395,"slug":"izmir","name":"Izmir","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":2500,"profile":{"city_type":"Aegean coastal port city in Turkey","access":["Izmir Airport (ADB), 14 km from the city center"],"sources":["https://en.wikipedia.org/wiki/%C4%B0zmir","https://en.wikipedia.org/wiki/Izmir_Adnan_Menderes_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Advanced or metastatic NSCLC with EGFR exon 19 deletion","Advanced or metastatic NSCLC with EGFR L858R mutation","Adjuvant therapy after resection of EGFR-mutated NSCLC","Unresectable stage III EGFR-mutated NSCLC after chemoradiotherapy"],"contraindications":["Severe hypersensitivity to osimertinib or its components.","Current interstitial lung disease or pneumonitis.","Congenital long QT syndrome or uncorrectable electrolyte disturbances.","Clinically significant cardiomyopathy or reduced ventricular function.","Strong CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St John's wort).","Pregnancy or planned conception (not recommended)."],"operation_hours":{"min":0.5,"max":3,"unit":"hours","qualifier":"Initial clinic visit for counseling and start; daily tablet takes minutes and therapy continues until progression."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":4,"max":8,"unit":"visits","qualifier":"Planned oncology reviews in the first 6 months from treatment start."},"stages":[{"code":"baseline_start","label":"Baseline assessment, counseling and start of daily oral therapy","after":{"min":0,"max":0,"unit":"days","qualifier":"Counted from treatment start."}},{"code":"early_tolerability_review","label":"Tolerability and laboratory review","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose."}},{"code":"first_response_assessment","label":"First response imaging and clinic review","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; timing varies by clinic."}},{"code":"ongoing_scheduled_reviews","label":"Ongoing reviews with periodic imaging every 2 to 3 months","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; later intervals individualized."}}],"qualifier":"Daily oral osimertinib after biomarker confirmation, continued until progression or intolerance. Counts cover first 6 months only."},"hospital_nights":{"value":{"min":0,"max":0,"unit":"nights","qualifier":"Oral therapy taken at home; no hospital stay in an uncomplicated course. Infusion-based regimens are outside this profile."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"min":0,"max":7,"unit":"days","qualifier":"Oral therapy without procedure; time to settle into daily routine, affected by rash, diarrhea, fatigue and disease burden."},"fly_home_after_days":{"min":0,"max":14,"unit":"days","qualifier":"No procedure; travel is possible after baseline workup, once stable with enough medication. Tolerability review at about 2–4 weeks."},"back_to_work_days":{"min":0,"max":7,"unit":"days","qualifier":"No procedure or stay; many patients with good performance status work within a week, adjusted for side effects."},"exercise_resume_weeks":{"min":0,"max":2,"unit":"weeks","qualifier":"Light activity from day 1; strenuous exercise gradually over 1 to 2 weeks if tolerability and breathing allow."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Time to first radiologic response assessment, about 6 to 12 weeks. Not a cure endpoint; therapy continues."},"result_longevity":"Disease control typically lasts months to a few years until resistance develops; median first-line progression-free survival was roughly 1.5 years. Benefit lasts only during therapy; not a cure.","main_risks":["Diarrhea, dry skin, rash, paronychia, mouth sores; usually manageable.","Interstitial lung disease: rare but serious; stop drug, urgent evaluation.","QT prolongation; rarely reduced heart function.","Low blood counts and liver enzyme changes found on monitoring.","Eye symptoms and rare severe skin reactions.","Drug interactions, especially with CYP3A4 inducers."],"complication_rate_pct":{"min":1,"max":5,"unit":"percent","qualifier":"Approximate rate of interstitial lung disease or pneumonitis on osimertinib; milder effects like rash and diarrhea are far more common."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Objective response rate (tumor shrinkage on imaging)","value":80,"horizon":"First response imaging, about 6 to 12 weeks after first dose","source":{"status":"missing","reason":"not_collected"},"evidence_status":"limited"},"scars":"None; no incisions.","pain":"Taking the oral tablet is painless. Treatment-related discomfort, such as mouth sores, nail-fold tenderness, rash or headache, can occur and is managed symptomatically.","preparation":["Confirm NSCLC and EGFR mutation by tissue or liquid biopsy","Baseline staging, usually CT with brain imaging, per the oncologist.","Baseline blood counts, liver and kidney tests, electrolytes","ECG and cardiac assessment as indicated","Review all medicines and supplements for CYP3A4 and QT interactions.","Counseling on side effects, dosing, skin and nail care","Contraception advice and when to contact the oncology team"],"recovery_timeline":[{"phase":"Treatment start (day 0)","description":"Baseline assessment and counseling, then daily oral osimertinib starts at home. No hospital stay; light activity continues from day 1.","restrictions":["Take the tablet daily as directed","Avoid interacting drugs and supplements unless cleared","Use contraception as advised"]},{"phase":"Days 1 to 28","description":"Mild diarrhea, dry skin, rash, nail changes, mouth sores and fatigue may appear; supportive care helps. Exercise resumes gradually.","restrictions":["Daily skin, nail and mouth care","Maintain hydration","Increase exercise gradually, guided by oncology team"]},{"phase":"Weeks 6 to 12","description":"First response imaging and clinic review; initial response is judged and monitoring continues.","restrictions":["Continue treatment unless the oncology team advises otherwise"]},{"phase":"Ongoing therapy (months 3 to 6 and beyond)","description":"Daily therapy with periodic reviews and imaging until progression or intolerance; repeat testing if disease progresses.","restrictions":["Continue regular monitoring as scheduled","Do not stop or change dose without oncology advice"]},{"phase":"At any time","description":"Seek urgent care for new cough, breathlessness, fever, chest pain, palpitations, severe diarrhea, severe rash, eye pain, or infection or bleeding signs.","restrictions":["Do not wait for the next review","Team may pause the drug during assessment"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose; tolerability and laboratory review."}},{"purpose":"result_review","requirement":"routine","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; first response imaging and clinic review."}},{"purpose":"assessment","requirement":"routine","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; periodic imaging every 2 to 3 months, later intervals individualized."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that the doctor explains the risks of any biopsy needed for the tumor before it is done","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Your doctor will explain the risks of having a biopsy for your type of tumor.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C2","text":"Check whether the doctor explains that cancer cells can become resistant to targeted therapy","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Cancer cells can become resistant to targeted therapy.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C3","text":"Check the plan for regular visits, blood tests and scans, which show whether the treatment is working","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"These regular visits and tests will help the doctor know whether the treatment is working.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C4","text":"Check that the side effects of the specific targeted drug you would receive are explained before treatment starts","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"The side effects that you may have depends on the type of targeted therapy you receive and how your body reacts to it.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C5","text":"Check that your tumor has been tested for drug targets, which is needed most of the time","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Promise that the doctor can know for certain how you will feel during treatment","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Doctors and nurses cannot know for certain how you will feel during treatment.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F2","text":"Ad or quote calling targeted therapy free of serious side effects","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But they have learned that targeted therapy can also cause serious side effects.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F3","text":"Targeted therapy offered without any mention of testing the tumor for drug targets","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"W2","text":"Worsening cough","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"W3","text":"Blood in sputum","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"EGFR mutation test","aliases":["EGFR mutation test","EGFR mutation","EGFR","tissue biopsy","liquid biopsy","EGFR and other biomarker test"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm NSCLC and EGFR mutation by tissue or liquid biopsy"},{"field":"initial_assessment_documents","text":"EGFR and other biomarker test report (NGS)"}],"what_it_checks":{"text":"Checks for lung tumor gene changes treatable with targeted therapy","source":{"url":"https://medlineplus.gov/lab-tests/lung-cancer-genetic-tests/","host":"medlineplus.gov","quote":"So, lung cancer genetic tests can help your provider find out whether your cancer has a gene change that may be treated with a targeted therapy.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Next-generation sequencing (NGS) test","aliases":["Next-generation sequencing (NGS) test","NGS","next-generation sequencing"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"EGFR and other biomarker test report (NGS)"}],"what_it_checks":{"text":"Checks several tumor gene changes in one test","source":{"url":"https://medlineplus.gov/lab-tests/lung-cancer-genetic-tests/","host":"medlineplus.gov","quote":"Because there are many types of gene changes that can be involved in NSCLC, your provider may check for several of these changes in one lung cancer genetic test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"Complete blood count","aliases":["Complete blood count","CBC","full blood count","blood counts"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"}],"what_it_checks":{"text":"Monitors blood cell counts that treatment may affect","source":{"url":"https://medlineplus.gov/lab-tests/complete-blood-count-cbc/","host":"medlineplus.gov","quote":"It is also used to monitor a condition or treatment that may affect your blood cell counts such as infections, anemia, immune system disorders, and blood cancers.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You may need to fast for several hours if other tests are ordered","source":{"url":"https://medlineplus.gov/lab-tests/complete-blood-count-cbc/","host":"medlineplus.gov","quote":"But if your provider ordered other tests on your blood sample, you may need to fast (not eat or drink) for several hours before the test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver tests","liver function","liver and kidney tests","liver and kidney function","LFT","Kidney function test","kidney tests","kidney function","RFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and kidney function"}],"what_it_checks":{"text":"Checks how well the liver works and whether it is damaged","source":{"url":"https://medlineplus.gov/lab-tests/liver-function-tests/","host":"medlineplus.gov","quote":"Some of these tests can show how well your liver is working and others can show whether your liver may be damaged by liver disease or injury.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You will probably need to fast for 10–12 hours before the test","source":{"url":"https://medlineplus.gov/lab-tests/liver-function-tests/","host":"medlineplus.gov","quote":"You will probably need to fast (not eat or drink) for 10-12 hours before the test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T5","name":"Electrolytes test","aliases":["Electrolytes test","electrolytes"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"}],"what_it_checks":{"text":"Checks for electrolyte, fluid, or pH imbalances","source":{"url":"https://medlineplus.gov/lab-tests/electrolyte-panel/","host":"medlineplus.gov","quote":"An electrolyte panel is used to check for electrolyte, fluid, or pH imbalances.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Blood tests","aliases":["Blood tests","recent blood tests"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent blood tests with liver and kidney function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"CT scan","aliases":["CT scan","CT","Chest CT"],"kind":"imaging","origin":[{"field":"preparation","text":"Baseline staging, usually CT with brain imaging, per the oncologist."},{"field":"initial_assessment_documents","text":"Chest CT or PET-CT report and images"}],"what_it_checks":{"text":"Makes detailed pictures of the chest and other body areas","source":{"url":"https://www.cancer.gov/types/lung/patient/small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"CT scan (CAT scan) uses a computer linked to an x-ray machine to make a series of detailed pictures of areas inside the body, such as the brain, chest, and abdomen.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Chest CT or PET-CT report and images"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"Remove jewellery and other objects containing metal before the scan","source":{"url":"https://www.nhs.uk/tests-and-treatments/pet-scan/","host":"nhs.uk","quote":"You'll need to remove any jewellery and other objects containing metal.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T9","name":"Brain imaging","aliases":["Brain imaging"],"kind":"imaging","origin":[{"field":"preparation","text":"Baseline staging, usually CT with brain imaging, per the oncologist."}],"what_it_checks":{"text":"Makes detailed pictures of the brain and other body areas","source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"CT scan (CAT scan) of the brain, chest, and abdomen uses a computer linked to an x-ray machine to make a series of detailed pictures of areas inside the body.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"Brain MRI","aliases":["Brain MRI","MRI"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Brain MRI report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"ok","items":[{"id":"P1","action":"Ask your treatment team whether your tumor needs biomarker testing before targeted therapy","why":"Testing shows whether the tumor has a target that a drug can attack","who_decides":"","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"visit_and_day":{"status":"ok","has_procedure_day":false,"items":[{"id":"V1","text":"Testing your cancer for targets that could help choose your treatment is called biomarker testing","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Testing your cancer for targets that could help choose your treatment is called biomarker testing.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V2","text":"A biopsy is a procedure in which your doctor removes a piece of the tumor for testing","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"A biopsy is a procedure in which your doctor removes a piece of the tumor for testing.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V3","text":"Your doctor will explain the risks of having a biopsy for your type of tumor","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Your doctor will explain the risks of having a biopsy for your type of tumor.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V4","text":"Targeted therapy uses drugs or other substances to identify and attack specific cancer cells","anesthesia":"any","source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"Targeted therapy uses drugs or other substances to identify and attack specific cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":0,"max":7,"unit":"days","qualifier":"No procedure or stay; many patients with good performance status work within a week, adjusted for side effects."},"complication_rate_pct":{"min":1,"max":5,"unit":"percent","qualifier":"Approximate rate of interstitial lung disease or pneumonitis on osimertinib; milder effects like rash and diarrhea are far more common."},"contraindications":["Severe hypersensitivity to osimertinib or its components.","Current interstitial lung disease or pneumonitis.","Congenital long QT syndrome or uncorrectable electrolyte disturbances.","Clinically significant cardiomyopathy or reduced ventricular function.","Strong CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St John's wort).","Pregnancy or planned conception (not recommended)."],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Oral therapy taken at home; no hospital stay in an uncomplicated course. Infusion-based regimens are outside this profile."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":2,"unit":"weeks","qualifier":"Light activity from day 1; strenuous exercise gradually over 1 to 2 weeks if tolerability and breathing allow."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Time to first radiologic response assessment, about 6 to 12 weeks. Not a cure endpoint; therapy continues."},"fly_home_after_days":{"min":0,"max":14,"unit":"days","qualifier":"No procedure; travel is possible after baseline workup, once stable with enough medication. Tolerability review at about 2–4 weeks."},"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose; tolerability and laboratory review."}},{"purpose":"result_review","requirement":"routine","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; first response imaging and clinic review."}},{"purpose":"assessment","requirement":"routine","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; periodic imaging every 2 to 3 months, later intervals individualized."}}],"indications":["Advanced or metastatic NSCLC with EGFR exon 19 deletion","Advanced or metastatic NSCLC with EGFR L858R mutation","Adjuvant therapy after resection of EGFR-mutated NSCLC","Unresectable stage III EGFR-mutated NSCLC after chemoradiotherapy"],"main_risks":["Diarrhea, dry skin, rash, paronychia, mouth sores; usually manageable.","Interstitial lung disease: rare but serious; stop drug, urgent evaluation.","QT prolongation; rarely reduced heart function.","Low blood counts and liver enzyme changes found on monitoring.","Eye symptoms and rare severe skin reactions.","Drug interactions, especially with CYP3A4 inducers."],"pain":"Taking the oral tablet is painless. Treatment-related discomfort, such as mouth sores, nail-fold tenderness, rash or headache, can occur and is managed symptomatically.","preparation":["Confirm NSCLC and EGFR mutation by tissue or liquid biopsy","Baseline staging, usually CT with brain imaging, per the oncologist.","Baseline blood counts, liver and kidney tests, electrolytes","ECG and cardiac assessment as indicated","Review all medicines and supplements for CYP3A4 and QT interactions.","Counseling on side effects, dosing, skin and nail care","Contraception advice and when to contact the oncology team"],"recovery_timeline":[{"phase":"Treatment start (day 0)","description":"Baseline assessment and counseling, then daily oral osimertinib starts at home. No hospital stay; light activity continues from day 1.","restrictions":["Take the tablet daily as directed","Avoid interacting drugs and supplements unless cleared","Use contraception as advised"]},{"phase":"Days 1 to 28","description":"Mild diarrhea, dry skin, rash, nail changes, mouth sores and fatigue may appear; supportive care helps. Exercise resumes gradually.","restrictions":["Daily skin, nail and mouth care","Maintain hydration","Increase exercise gradually, guided by oncology team"]},{"phase":"Weeks 6 to 12","description":"First response imaging and clinic review; initial response is judged and monitoring continues.","restrictions":["Continue treatment unless the oncology team advises otherwise"]},{"phase":"Ongoing therapy (months 3 to 6 and beyond)","description":"Daily therapy with periodic reviews and imaging until progression or intolerance; repeat testing if disease progresses.","restrictions":["Continue regular monitoring as scheduled","Do not stop or change dose without oncology advice"]},{"phase":"At any time","description":"Seek urgent care for new cough, breathlessness, fever, chest pain, palpitations, severe diarrhea, severe rash, eye pain, or infection or bleeding signs.","restrictions":["Do not wait for the next review","Team may pause the drug during assessment"]}],"rehabilitation_days":{"min":0,"max":7,"unit":"days","qualifier":"Oral therapy without procedure; time to settle into daily routine, affected by rash, diarrhea, fatigue and disease burden."},"result_longevity":"Disease control typically lasts months to a few years until resistance develops; median first-line progression-free survival was roughly 1.5 years. Benefit lasts only during therapy; not a cure.","revision_rate_pct":null,"scars":"None; no incisions.","sessions_or_stages":{"sessions":{"min":4,"max":8,"unit":"visits","qualifier":"Planned oncology reviews in the first 6 months from treatment start."},"stages":[{"code":"baseline_start","label":"Baseline assessment, counseling and start of daily oral therapy","after":{"min":0,"max":0,"unit":"days","qualifier":"Counted from treatment start."}},{"code":"early_tolerability_review","label":"Tolerability and laboratory review","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose."}},{"code":"first_response_assessment","label":"First response imaging and clinic review","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; timing varies by clinic."}},{"code":"ongoing_scheduled_reviews","label":"Ongoing reviews with periodic imaging every 2 to 3 months","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; later intervals individualized."}}],"qualifier":"Daily oral osimertinib after biomarker confirmation, continued until progression or intolerance. Counts cover first 6 months only."},"success":{"metric":"Objective response rate (tumor shrinkage on imaging)","value":80,"unit":"percent","horizon":"First response imaging, about 6 to 12 weeks after first dose","population":"Adults with advanced EGFR exon 19 or L858R NSCLC on first-line osimertinib","evidence_status":"limited"},"techniques":[{"name":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","suits_whom":"Adults with EGFR-mutated advanced NSCLC.","recovery":"Taken at home daily; no procedural recovery, with side-effect management and monitoring as directed."},{"name":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","suits_whom":"Patients with the matching actionable alteration; the choice follows biomarker results and approvals.","recovery":"Taken at home as continuous therapy; monitoring and side effects are agent-specific."},{"name":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","suits_whom":"Selected patients with specific alterations or after progression on oral inhibitors; availability varies.","recovery":"Given by intravenous infusion in a treatment unit; schedules and observation are product-specific."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":0.5,"max":3,"unit":"hours","qualifier":"Initial clinic visit for counseling and start; daily tablet takes minutes and therapy continues until progression."},"initial_assessment_documents":["Lung biopsy pathology report","EGFR and other biomarker test report (NGS)","Chest CT or PET-CT report and images","Brain MRI report","Recent blood tests with liver and kidney function","Previous cancer treatment summary (if available)"],"travel_trips":{"min":1,"max":3,"one_trip_possible":true,"qualifier":"Daily oral therapy; one 1-2 week trip covers workup and start; imaging and reviews may need return trips."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that the doctor explains the risks of any biopsy needed for the tumor before it is done","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Your doctor will explain the risks of having a biopsy for your type of tumor.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C2","text":"Check whether the doctor explains that cancer cells can become resistant to targeted therapy","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Cancer cells can become resistant to targeted therapy.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C3","text":"Check the plan for regular visits, blood tests and scans, which show whether the treatment is working","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"These regular visits and tests will help the doctor know whether the treatment is working.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C4","text":"Check that the side effects of the specific targeted drug you would receive are explained before treatment starts","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"The side effects that you may have depends on the type of targeted therapy you receive and how your body reacts to it.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C5","text":"Check that your tumor has been tested for drug targets, which is needed most of the time","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Promise that the doctor can know for certain how you will feel during treatment","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Doctors and nurses cannot know for certain how you will feel during treatment.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F2","text":"Ad or quote calling targeted therapy free of serious side effects","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But they have learned that targeted therapy can also cause serious side effects.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F3","text":"Targeted therapy offered without any mention of testing the tumor for drug targets","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"W2","text":"Worsening cough","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"W3","text":"Blood in sputum","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your lung cancer can be removed with surgery","name":"Lung cancer surgery","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment/","host":"nhs.uk","quote":"You may have surgery to remove cancer from your lung.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200},"operation_id":374}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"technique_details":{"status":"ok","items":[{"id":"oral-egfr-tyrosine","name":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"other-oral-targeted","name":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"antibody-based-targeted","name":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"EGFR mutation test","aliases":["EGFR mutation test","EGFR mutation","EGFR","tissue biopsy","liquid biopsy","EGFR and other biomarker test"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm NSCLC and EGFR mutation by tissue or liquid biopsy"},{"field":"initial_assessment_documents","text":"EGFR and other biomarker test report (NGS)"}],"what_it_checks":{"text":"Checks for lung tumor gene changes treatable with targeted therapy","source":{"url":"https://medlineplus.gov/lab-tests/lung-cancer-genetic-tests/","host":"medlineplus.gov","quote":"So, lung cancer genetic tests can help your provider find out whether your cancer has a gene change that may be treated with a targeted therapy.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Next-generation sequencing (NGS) test","aliases":["Next-generation sequencing (NGS) test","NGS","next-generation sequencing"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"EGFR and other biomarker test report (NGS)"}],"what_it_checks":{"text":"Checks several tumor gene changes in one test","source":{"url":"https://medlineplus.gov/lab-tests/lung-cancer-genetic-tests/","host":"medlineplus.gov","quote":"Because there are many types of gene changes that can be involved in NSCLC, your provider may check for several of these changes in one lung cancer genetic test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"Complete blood count","aliases":["Complete blood count","CBC","full blood count","blood counts"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"}],"what_it_checks":{"text":"Monitors blood cell counts that treatment may affect","source":{"url":"https://medlineplus.gov/lab-tests/complete-blood-count-cbc/","host":"medlineplus.gov","quote":"It is also used to monitor a condition or treatment that may affect your blood cell counts such as infections, anemia, immune system disorders, and blood cancers.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You may need to fast for several hours if other tests are ordered","source":{"url":"https://medlineplus.gov/lab-tests/complete-blood-count-cbc/","host":"medlineplus.gov","quote":"But if your provider ordered other tests on your blood sample, you may need to fast (not eat or drink) for several hours before the test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver tests","liver function","liver and kidney tests","liver and kidney function","LFT","Kidney function test","kidney tests","kidney function","RFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and kidney function"}],"what_it_checks":{"text":"Checks how well the liver works and whether it is damaged","source":{"url":"https://medlineplus.gov/lab-tests/liver-function-tests/","host":"medlineplus.gov","quote":"Some of these tests can show how well your liver is working and others can show whether your liver may be damaged by liver disease or injury.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You will probably need to fast for 10–12 hours before the test","source":{"url":"https://medlineplus.gov/lab-tests/liver-function-tests/","host":"medlineplus.gov","quote":"You will probably need to fast (not eat or drink) for 10-12 hours before the test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T5","name":"Electrolytes test","aliases":["Electrolytes test","electrolytes"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"}],"what_it_checks":{"text":"Checks for electrolyte, fluid, or pH imbalances","source":{"url":"https://medlineplus.gov/lab-tests/electrolyte-panel/","host":"medlineplus.gov","quote":"An electrolyte panel is used to check for electrolyte, fluid, or pH imbalances.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Blood tests","aliases":["Blood tests","recent blood tests"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent blood tests with liver and kidney function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"CT scan","aliases":["CT scan","CT","Chest CT"],"kind":"imaging","origin":[{"field":"preparation","text":"Baseline staging, usually CT with brain imaging, per the oncologist."},{"field":"initial_assessment_documents","text":"Chest CT or PET-CT report and images"}],"what_it_checks":{"text":"Makes detailed pictures of the chest and other body areas","source":{"url":"https://www.cancer.gov/types/lung/patient/small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"CT scan (CAT scan) uses a computer linked to an x-ray machine to make a series of detailed pictures of areas inside the body, such as the brain, chest, and abdomen.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Chest CT or PET-CT report and images"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"Remove jewellery and other objects containing metal before the scan","source":{"url":"https://www.nhs.uk/tests-and-treatments/pet-scan/","host":"nhs.uk","quote":"You'll need to remove any jewellery and other objects containing metal.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T9","name":"Brain imaging","aliases":["Brain imaging"],"kind":"imaging","origin":[{"field":"preparation","text":"Baseline staging, usually CT with brain imaging, per the oncologist."}],"what_it_checks":{"text":"Makes detailed pictures of the brain and other body areas","source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"CT scan (CAT scan) of the brain, chest, and abdomen uses a computer linked to an x-ray machine to make a series of detailed pictures of areas inside the body.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"Brain MRI","aliases":["Brain MRI","MRI"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Brain MRI report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"ok","items":[{"id":"P1","action":"Ask your treatment team whether your tumor needs biomarker testing before targeted therapy","why":"Testing shows whether the tumor has a target that a drug can attack","who_decides":"","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"visit_and_day":{"status":"ok","has_procedure_day":false,"items":[{"id":"V1","text":"Testing your cancer for targets that could help choose your treatment is called biomarker testing","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Testing your cancer for targets that could help choose your treatment is called biomarker testing.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V2","text":"A biopsy is a procedure in which your doctor removes a piece of the tumor for testing","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"A biopsy is a procedure in which your doctor removes a piece of the tumor for testing.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V3","text":"Your doctor will explain the risks of having a biopsy for your type of tumor","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Your doctor will explain the risks of having a biopsy for your type of tumor.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V4","text":"Targeted therapy uses drugs or other substances to identify and attack specific cancer cells","anesthesia":"any","source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"Targeted therapy uses drugs or other substances to identify and attack specific cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"}}},"techniques":[{"id":"oral-egfr-tyrosine","name":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Adults with EGFR-mutated advanced NSCLC.","price_from":5000,"recovery":"Taken at home daily; no procedural recovery, with side-effect management and monitoring as directed."},{"id":"other-oral-targeted","name":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Patients with the matching actionable alteration; the choice follows biomarker results and approvals.","price_from":5000,"recovery":"Taken at home as continuous therapy; monitoring and side effects are agent-specific."},{"id":"antibody-based-targeted","name":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Selected patients with specific alterations or after progression on oral inhibitors; availability varies.","price_from":5500,"recovery":"Given by intravenous infusion in a treatment unit; schedules and observation are product-specific."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your lung cancer can be removed with surgery","name":"Lung cancer surgery","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment/","host":"nhs.uk","quote":"You may have surgery to remove cancer from your lung.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200},"operation_id":374}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"ok","items":[{"id":"Y1","text":"Turkey's Ministry of Health publishes lists of authorized healthcare providers and facilitators holding authorization certificates","specialties":[],"source":{"url":"https://shgmturizmdb.saglik.gov.tr/EN-69410/announcements.html","host":"shgmturizmdb.saglik.gov.tr","quote":"Updated lists of healthcare providers and facilitators that have been granted authorization certificates by the Ministry","tier":"government","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-05-11","version":1},"travel":{"status":"ok","items":[{"id":"V1","item":"visa","audience":"uk","volatile":true,"text":"UK citizen passport holders can visit Turkey without a visa for up to 90 days in any 180-day period, for business or tourism","source":{"url":"https://www.gov.uk/foreign-travel-advice/turkey/entry-requirements","host":"gov.uk","quote":"You can visit Turkey without a visa for up to 90 days in any 180-day period, for business or tourism.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"visa","audience":"us","volatile":true,"text":"US ordinary passport holders are exempt from a visa for up to 90 days in any 180-day period in Turkey","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Turkey.html","host":"travel.state.gov","quote":"Ordinary passport holders are exempted from visa up to 90 days in any 180-day period.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"passport_validity","audience":"uk","volatile":true,"text":"A UK passport must expire at least 150 days after arrival in Turkey and have at least 1 blank page","source":{"url":"https://www.gov.uk/foreign-travel-advice/turkey/entry-requirements","host":"gov.uk","quote":"To enter Turkey, your passport must have an ‘expiry date’ at least 150 days after the date you arrive and at least 1 blank page.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V4","item":"passport_validity","audience":"us","volatile":true,"text":"A US passport must be valid for six months beyond the entry date into Turkey","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Turkey.html","host":"travel.state.gov","quote":"Passports must be valid for six months beyond your entry date.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V5","item":"prescriptions","audience":"uk","volatile":false,"text":"British prescriptions are not accepted in pharmacies in Turkey","source":{"url":"https://www.gov.uk/foreign-travel-advice/turkey/health","host":"gov.uk","quote":"British prescriptions are not accepted in pharmacies in Turkey.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V6","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 112 and ask for an ambulance in Turkey","source":{"url":"https://www.gov.uk/foreign-travel-advice/turkey/health","host":"gov.uk","quote":"Dial 112 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["china","egypt","germany","india","republic-of-korea","spain","switzerland","thailand","ukraine"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.57,"count":1463,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p class=\"bm-h1-lead\">Target therapy for lung cancer in Turkey is offered by Hisar Hospital Intercontinental, a JCI-accredited clinic in Istanbul. The clinic is rated 4.5/5 in 266 verified patient reviews on Bookimed.</p>","faq":[{"q":"How is lung cancer targeted therapy administered in Turkey?","a":"<p>Lung cancer targeted therapy in Turkey is administered as a personalized regimen based on molecular testing for mutations like EGFR or ALK. Patients receive either daily oral tablets at home or intravenous infusions during three-hour outpatient sessions at JCI-accredited hospitals in Istanbul and Ankara.</p> <ul> <li><strong>Molecular screening:</strong> Doctors perform genetic sequencing to identify biomarkers before starting specific targeted drugs.</li> <li><strong>Oral administration:</strong> Patients take small molecule inhibitors like Crizotinib as daily capsules at home.</li> <li><strong>Intravenous infusion:</strong> Medical teams administer monoclonal antibodies via IV every 2 to 3 weeks.</li> <li><strong>Clinical monitoring:</strong> Multidisciplinary tumor boards at centers like Anadolu Medical Center review progress scans.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Genetic testing turnaround is a major differentiator for international patients in Turkey. While some global centers take weeks, specialized private labs in Istanbul often deliver NGS results within 7 days. This speed allows surgeons like those at Memorial Şişli Hospital to initiate precise therapy protocols almost immediately after diagnosis.</p> <p><strong>Patient Consensus:</strong> Patients value the ability to manage oral treatments from home after the initial setup. Many suggest bringing a 2-month supply of medications to avoid potential local pharmacy delays during their stay.</p>"},{"q":"What exactly is targeted therapy for lung cancer?","a":"<p>Targeted therapy is a precision cancer treatment using drugs to block specific genetic mutations, such as EGFR or ALK, that fuel tumor growth. Unlike chemotherapy, these medications primarily attack cancer cells with molecular typos, preserving healthy tissue and significantly reducing systemic side effects.</p> <ul> <li><strong>Treatment mechanism:</strong> Drugs act as a lock and key to block growth-signaling proteins.</li> <li><strong>Common targets:</strong> Doctors test for EGFR, ALK, KRAS, and ROS1 mutations before prescribing.</li> <li><strong>Administration method:</strong> Many patients take daily oral pills at home instead of IV infusions.</li> <li><strong>Outpatient nature:</strong> Therapy is typically outpatient, requiring regular imaging every 6 to 8 weeks.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Turkish oncology centers like Anadolu Medical Center frequently offer faster access to next-generation genomic sequencing. While public systems may face delays, private JCI-accredited clinics often deliver comprehensive biomarker panels in 2 weeks. This speed is critical for matching patients with specific inhibitors like Osimertinib or Alectinib before the disease progresses.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the necessity of requesting a rush genetic panel for EGFR and PD-L1 mutations. They often report that skin rashes and fatigue are manageable with pre-planned supportive care from their oncology teams.</p>"},{"q":"Is targeted therapy safe and what are the main risks?","a":"<p>Targeted therapy is generally safe and more precise than chemotherapy, focusing on specific proteins in cancer cells. However, it can affect healthy cells, leading to manageable side effects like skin rashes and diarrhea, or rare but serious complications involving cardiovascular health, liver toxicity, and internal bleeding.</p> <ul> <li><strong>Cardiovascular monitoring:</strong> Doctors track blood pressure and heart rhythm to prevent hypertension or heart failure.</li> <li><strong>Organ toxicity:</strong> Regular blood tests monitor liver enzymes and thyroid function for potential drug-induced damage.</li> <li><strong>Skin changes:</strong> Acne-like rashes or extreme dryness occur frequently but are handled with specialized creams.</li> <li><strong>Gastrointestinal care:</strong> Chronic diarrhea requires proactive hydration and probiotics to maintain gut health during treatment.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Top Turkish centers like Anadolu Medical Center and Memorial Bahçelievler maintain safety through elite affiliations, such as with Johns Hopkins Medicine. Data shows these clinics prioritize long-term stability by integrating monthly molecular monitoring. This helps specialists like Dr. Eda Tanrikulu detect treatment resistance early, typically within 12 to 24 months, allowing for immediate therapy adjustments before symptoms worsen.</p> <p><strong>Patient Consensus:</strong> Many patients describe the side effects as manageable compared to traditional chemo, though skin rashes can feel like a return to puberty. Success relies on keeping a daily symptom log and having a proactive care kit ready to handle sudden digestive or skin flare-ups.</p>"},{"q":"Who is eligible for targeted therapy in Turkey?","a":"<p>Eligibility for targeted therapy in Turkey depends on the molecular profile of the tumor rather than cancer stage alone. Patients must undergo specialized genetic testing, such as Next-Generation Sequencing (NGS), to identify specific mutations like EGFR, ALK, or ROS1 before starting treatment.</p> <ul> <li><strong>Genetic testing requirement:</strong> Modern diagnostics must confirm specific markers like HER2, KRAS, or BRAF mutations.</li> <li><strong>Disease stage:</strong> Often prescribed for advanced Stage 4 or metastatic cancers that spread.</li> <li><strong>Treatment history:</strong> Patients who did not respond to standard chemotherapy are primary candidates.</li> <li><strong>Clinical health:</strong> Patients need a stable performance status to manage potential therapy side effects.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many local clinics offer basic oncology, major centers like Anadolu Medical Center provide comprehensive mutation panels through affiliations with global leaders like Johns Hopkins. Choosing a JCI-accredited facility in Istanbul ensures access to approximately 62% of all FDA-approved targeted drugs, often saving patients _price_percent_discount_% compared to US costs.</p> <p><strong>Patient Consensus:</strong> Patients emphasize securing a biopsy and a full NGS testing report before visiting. Many suggest targeting university-affiliated hospitals for the most diverse testing panels and faster results.</p>"},{"q":"How long will I stay in Turkey for targeted therapy?","a":"<p>Patients typically stay in Turkey for 7 to 28 days for lung cancer targeted therapy. A short-term 3 to 7-day visit covers initial diagnostic workups and starting oral medications. Intravenous infusions or comprehensive genetic testing for EGFR or ALK mutations usually require 2 to 4 weeks.</p> <ul> <li><strong>Initial workup:</strong> Diagnostics, PET scans, and biopsy confirmation usually take 3 to 7 days.</li> <li><strong>Mutation testing:</strong> Confirming genetic markers for targeted drugs often extends stays to 14 days.</li> <li><strong>Infusion cycles:</strong> Intravenous therapies typically follow 21 to 28-day cycles for monitoring immune response.</li> <li><strong>Monitoring period:</strong> Top clinics prioritize 7 days of observation to manage potential side effects like fatigue.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Data from high-volume centers like Anadolu Medical Center, which is affiliated with Johns Hopkins, shows that mutation testing is the primary stay-extender. You can often reduce your stay from 3 weeks to 1 week by sharing existing pathology blocks for pre-arrival review. This allows oncologists like Dr. Eda Tanrikulu to finalize the protocol before you land in Istanbul.</p> <p><strong>Patient Consensus:</strong> Patients recommend planning at least 2 weeks for the first trip to account for testing delays. Many travelers suggest booking during off-peak seasons to cut clinic wait times significantly.</p>"},{"q":"Which drugs are available in Turkey for each genetic alteration?","a":"<p>Turkish oncology centers provide access to approximately 62.7% of FDA-approved targeted therapies for lung cancer. Core drugs for EGFR, ALK, and ROS1 mutations are widely available at JCI-accredited institutions. Access is managed through local licensure or the Turkish Medicines and Medical Devices Agency Annex 4-C import program.</p> <ul> <li><strong>EGFR drugs:</strong> Osimertinib, Gefitinib, and Erlotinib are available for exon 19del or L858R mutations.</li> <li><strong>ALK/ROS1 drugs:</strong> Alectinib and Crizotinib are standard; Entrectinib may require specialized import protocols.</li> <li><strong>BRAF/MET drugs:</strong> Dabrafenib and Trametinib combinations are sporadically imported for V600E-positive lung cases.</li> <li><strong>KRAS inhibitors:</strong> Sotorasib access remains limited, primarily found through private trials or specific imports.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Anadolu Medical Center maintains a Johns Hopkins affiliation, granting patients access to international protocols that often bridge licensure gaps. Data shows centers like Hisar Hospital prioritize comprehensive NGS testing for around $1,000. This is a critical first step because the Turkish system requires genetic proof before approving high-cost imports like Brigatinib.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that while public approval waits can last 2 to 3 months, private centers offer immediate access. Many recommend joining local support groups to track real-time stock levels for newer inhibitors like Sotorasib.</p>"},{"q":"How will we measure success and what outcomes can I expect?","a":"<p>Success in target therapy for lung cancer is primarily measured by tumor shrinkage and symptom relief. Patients typically observe reduced breathlessness and increased energy within 2 to 6 weeks. Clinical success is confirmed via CT or PET scans every 8 to 12 weeks using RECIST criteria.</p> <ul> <li><strong>Tumor response:</strong> Doctors look for 30% or more shrinkage during quarterly diagnostic imaging scans.</li> <li><strong>Disease control:</strong> Next-generation inhibitors like osimertinib often provide 24 or more months of stability.</li> <li><strong>Resistance monitoring:</strong> Liquid biopsies or next-generation sequencing (NGS) detect new mutations if progression occurs.</li> <li><strong>Clinical monitoring:</strong> Monthly blood tests and specialist consultations track treatment tolerance and organ function.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many focus on scans, the real differentiator in Turkish centers like Anadolu Medical Center is access to international clinical trials. Their affiliation with Johns Hopkins allows patients to transition to experimental therapies immediately when standard targeted drugs stop working. This seamless move between approved inhibitors and trial drugs often extends survival significantly beyond the initial 12-month projection.</p> <p><strong>Patient Consensus:</strong> Many patients report feeling a dramatic return of energy and reduced coughing long before their first official scan. They emphasize the importance of tracking daily quality of life metrics alongside clinical data to stay motivated during long-term treatment.</p>"},{"q":"What post-treatment surveillance plan should I follow after returning home?","a":"<p>Post-treatment surveillance for lung cancer targeted therapy in Turkey requires monthly bloodwork and diagnostic imaging every 3 to 6 months. Your plan should include specific monitoring for resistance patterns, medication adherence tracking, and symptom education for oral tyrosine kinase inhibitors or intravenous immunotherapy combinations.</p> <ul> <li><strong>Imaging schedule:</strong> Perform CT or PET-CT scans every 3 months initially to catch resistance early.</li> <li><strong>Diagnostic monitoring:</strong> Conduct monthly blood tests and track tumor markers like CEA for stability signs.</li> <li><strong>Symptom journaling:</strong> Record daily fatigue, weight, and O2 levels to identify subtle disease progression.</li> <li><strong>Red flag alerts:</strong> Contact your oncologist immediately for new cough, bone pain, or worsening breathlessness.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Clinics like Anadolu Medical Center provide survivorship plans affiliated with Johns Hopkins standards. Data shows that patients using high-tier centers in Istanbul often receive more frequent 3-month imaging cycles. This aggressive monitoring is vital for targeted therapies like Osimertinib where resistance can develop rapidly.</p> <p><strong>Patient Consensus:</strong> Many patients recommend using a portable pulse oximeter at home for weekly oxygen checks. They emphasize that tracking every dose is essential to prevent breakthrough progression while recovering at home.</p>"}],"h2":[{"text":"Quel est le Coût pour votre Thérapie ciblée pour le cancer du poumon en Turquie ?","kind":"content"},{"text":"Vos avantages et garanties avec Bookimed","kind":"content"},{"text":"Votre coordinateur médical personnel","kind":"content"},{"text":"Découvrez les Meilleures Cliniques pour Votre Thérapie ciblée pour le cancer du poumon en Turquie : 8 Options Vérifiées et Prix","kind":"content"},{"text":"Aperçu de thérapie ciblée pour le cancer du poumon en Turquie","kind":"content"},{"text":"Obtenez une Évaluation Médicale pour Votre Thérapie ciblée pour le cancer du poumon en Turquie : Consultez Maintenant 12 Médecins Expérimentés","kind":"content"},{"text":"Histoires vidéo des patients de Bookimed","kind":"content"},{"text":"Avis sur Bookimed : Découvrez l'Expérience des Patients","kind":"content"},{"text":"Partager ce contenu","kind":"content"},{"text":"FAQ de thérapie ciblée pour le cancer du poumon en Turquie","kind":"content"},{"text":"Obtenez une consultation gratuite","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}